These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 34059986

  • 21. Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.
    Ming L, Cao HL, Li Q, Yu G.
    Pediatr Cardiol; 2021 Oct; 42(7):1496-1503. PubMed ID: 34036412
    [Abstract] [Full Text] [Related]

  • 22. Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.
    Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
    Clin Rheumatol; 2022 Jan; 41(1):137-145. PubMed ID: 34363547
    [Abstract] [Full Text] [Related]

  • 23. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G, Jianming L, Suqian T, Dong Q, Shuang L, Jin Z.
    BMC Pediatr; 2022 Jan 07; 22(1):29. PubMed ID: 34996405
    [Abstract] [Full Text] [Related]

  • 24. Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.
    Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Matsubara Y, Matsubara D, Kosami K, Sasahara T, Belay ED.
    Am Heart J; 2020 Jul 07; 225():120-128. PubMed ID: 32497905
    [Abstract] [Full Text] [Related]

  • 25. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S.
    J Pediatr; 2000 Aug 07; 137(2):177-80. PubMed ID: 10931408
    [Abstract] [Full Text] [Related]

  • 26. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 07; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 27. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
    Zhao CN, Du ZD, Gao LL.
    Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036
    [Abstract] [Full Text] [Related]

  • 28. Facial palsy in Kawasaki syndrome.
    Bushara K, Wilson A, Rust RS.
    Pediatr Neurol; 1997 Nov 20; 17(4):362-4. PubMed ID: 9436804
    [Abstract] [Full Text] [Related]

  • 29. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
    Pediatr Neonatol; 2014 Oct 20; 55(5):387-92. PubMed ID: 24636168
    [Abstract] [Full Text] [Related]

  • 30. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 27; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 32. Kawasaki Disease With Coronary Artery Lesions Detected at Initial Echocardiography.
    Ae R, Maddox RA, Abrams JY, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Kosami K, Matsubara Y, Matsubara D, Sasahara T, Belay ED.
    J Am Heart Assoc; 2021 Apr 06; 10(7):e019853. PubMed ID: 33787310
    [Abstract] [Full Text] [Related]

  • 33. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Apr 06; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 34. Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions.
    Wang L, Yang Y, Cui Q, Cui Y, Li Q, Che X, Wang C, Quan P, Hu X.
    J Investig Med; 2021 Jan 06; 69(1):13-19. PubMed ID: 33004469
    [Abstract] [Full Text] [Related]

  • 35. Coronary artery aneurysm and facial drooping in a infant with Kawasaki disease.
    Yuan Y, Lu N.
    Cardiol Young; 2020 Dec 06; 30(12):1957-1959. PubMed ID: 32972477
    [Abstract] [Full Text] [Related]

  • 36. Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.
    Wang N, Gao Y, Wang Y, Dai Y, Tang Y, Huang J, Sun L, Qian G, Ma J, Li X, Liu Y, Yang D, Huang X, Wang W, Li W, Zhuo W, Lv H, Liu Z.
    Int Immunopharmacol; 2024 Sep 30; 139():112698. PubMed ID: 39029232
    [Abstract] [Full Text] [Related]

  • 37. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
    Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
    Int Immunopharmacol; 2023 Sep 30; 122():110600. PubMed ID: 37423157
    [Abstract] [Full Text] [Related]

  • 38. Development of a prediction model for progression of coronary artery lesions in Kawasaki disease.
    Xu D, Chen YS, Feng CH, Cao AM, Li XH.
    Pediatr Res; 2024 Mar 30; 95(4):1041-1050. PubMed ID: 38040988
    [Abstract] [Full Text] [Related]

  • 39. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X, He Y, Shao Y, Hang B, Xu Z, Chu M.
    Pediatr Rheumatol Online J; 2021 Jun 26; 19(1):96. PubMed ID: 34174872
    [Abstract] [Full Text] [Related]

  • 40. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.
    J Microbiol Immunol Infect; 2007 Oct 26; 40(5):395-400. PubMed ID: 17932598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.